A High-Content Glucocorticoid Receptor Translocation Assay for Compound Mechanism-of-Action Evaluation

Ligand-induced cytoplasm to nucleus translocation is a critical event in the nuclear receptor (NR) signal transduction cascade. The development of green fluorescent proteins and their color variants fused with NRs, along with the recent developments in automated cellular imaging technologies, has provided unique tools to monitor and quantify the NR translocation events. These technology developments have important implications in the mechanistic evaluation of NR signaling and provide a powerful tool for drug discovery. The unique challenges for developing a robust NR translocation assay include cytotoxicity accompanied with chronic overexpression of NRs, basal translocation induced by serum present in culture medium, and interference from endogenous NRs, as well as subcellular dynamics. The authors have developed a robust assay system for the glucocorticoid receptor (GR) that was applied to a panel of nuclear receptor ligands. Using a high-content imaging system, ligand-induced, dose-dependent GR nuclear translocation was quantified and a correlation with other conventional assays established. (Journal of Biomolecular Screening 2007:1029-1041)

[1]  Guy Cavet,et al.  Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. , 2008, Cancer research.

[2]  Michael G. Rosenfeld,et al.  Controlling nuclear receptors: the circular logic of cofactor cycles , 2005, Nature Reviews Molecular Cell Biology.

[3]  C. Parker,et al.  Multiplexing Nuclear Receptors for Agonist Identification in a Cell-Based Reporter Gene High-Throughput Screen , 2003, Journal of biomolecular screening.

[4]  G. Fink,et al.  A Drug-Sensitive Genetic Network Masks Fungi from the Immune System , 2006, PLoS pathogens.

[5]  Gregory J. Parker,et al.  Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand-Binding and Kinase/Phosphatase Assays , 2000, Journal of biomolecular screening.

[6]  G. Banker,et al.  Activated c-Jun N-Terminal Kinase Is Required for Axon Formation , 2006, The Journal of Neuroscience.

[7]  Rick B. Vega,et al.  Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5 , 2004, Molecular and Cellular Biology.

[8]  J. Yingling,et al.  A small molecule inhibitor of TGFβ RI kinase potentiates VEGF dependent angiogenesis in vitro , 2006 .

[9]  M. Favata,et al.  A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract. , 2002, Analytical biochemistry.

[10]  Zhengrong Zhu,et al.  Use of Cryopreserved Transiently Transfected Cells in High-Throughput Pregnane X Receptor Transactivation Assay , 2007, Journal of biomolecular screening.

[11]  J. Dunlop,et al.  Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization , 2004, Journal of Pharmacology and Experimental Therapeutics.

[12]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[13]  G. Zhou,et al.  Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. , 2001, Methods.

[14]  D. Ruderman,et al.  The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. , 2007, Neoplasia.

[15]  M. Kawata,et al.  Visualization of Glucocorticoid Receptor and Mineralocorticoid Receptor Interactions in Living Cells with GFP-Based Fluorescence Resonance Energy Transfer , 2004, The Journal of Neuroscience.

[16]  M. Pangalos,et al.  Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities , 2008, Proceedings of the National Academy of Sciences.

[17]  Paul Workman,et al.  The contemporary drug development process: advances and challenges in preclinical and clinical development. , 2003, Progress in cell cycle research.

[18]  S. Mutka,et al.  Identification of nuclear export inhibitors with potent anticancer activity in vivo. , 2009, Cancer research.

[19]  O. J. Trask,et al.  Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway , 2007, Molecular Cancer Therapeutics.

[20]  T. Kenakin,et al.  The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property? , 2009, Molecular Pharmacology.

[21]  Jing Zhang,et al.  High-content screening moves to the front of the line. , 2006, Drug discovery today.

[22]  J. George,et al.  MicroRNA‐134 Modulates the Differentiation of Mouse Embryonic Stem Cells, Where It Causes Post‐Transcriptional Attenuation of Nanog and LRH1 , 2008, Stem cells.

[23]  P. Wipf,et al.  Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1 , 2009, Journal of Pharmacology and Experimental Therapeutics.

[24]  J. Lazo,et al.  Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases. , 2007, Methods.

[25]  R. Eglen,et al.  A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation. , 2006, Assay and drug development technologies.

[26]  J. McNally,et al.  The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. , 2000, Science.

[27]  James Wilhelm,et al.  The Structure of the Lingo-1 Ectodomain, a Module Implicated in Central Nervous System Repair Inhibition* , 2006, Journal of Biological Chemistry.

[28]  R. Medema,et al.  RAMA1 is a novel kinetochore protein involved in kinetochore-microtubule attachment , 2009, Journal of Cell Science.

[29]  G. Sczakiel,et al.  Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells , 2006, Molecular Cancer Therapeutics.

[30]  S. Kain,et al.  Green fluorescent protein (GFP): applications in cell-based assays for drug discovery. , 1999, Drug discovery today.

[31]  John A. Tallarico,et al.  Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.

[32]  S. Ishiwata,et al.  Inter-sarcomere coordination in muscle revealed through individual sarcomere response to quick stretch , 2009, Proceedings of the National Academy of Sciences.

[33]  D. Pearce,et al.  Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Hager,et al.  Trafficking of nuclear receptors in living cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  M. Galigniana,et al.  Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. , 1997, Biochemistry.

[36]  C. Pariante,et al.  The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. , 2001, The Journal of endocrinology.

[37]  T. Hughes,et al.  Prediction and Testing of Novel Transcriptional Networks Regulating Embryonic Stem Cell Self-renewal and Commitment , 2022 .

[38]  Rajesh Odedra,et al.  AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis , 2007, Clinical Cancer Research.

[39]  Wenhan Lin,et al.  Induction of apoptosis accompanying with G(1) phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene. , 2008, Cancer letters.

[40]  Xin Xie,et al.  Development of a quantitative, cell-based, high-content screening assay for epidermal growth factor receptor modulators , 2007, Acta Pharmacologica Sinica.

[41]  Peter R. McDonald,et al.  A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells , 2008, Molecular Cancer Therapeutics.

[42]  D. Bolognini,et al.  Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators* , 2007, Journal of Biological Chemistry.

[43]  Jussi Taipale,et al.  Identification of pathways regulating cell size and cell-cycle progression by RNAi , 2006, Nature.

[44]  Anders Isaksson,et al.  Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. , 2007, Biochemical pharmacology.

[45]  Hiroshi Yasui,et al.  SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK. , 2009, Blood.

[46]  B. Darimont,et al.  The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-β-Catenin Complex* , 2006, Journal of Biological Chemistry.

[47]  Paul A Johnston,et al.  Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform. , 2006, Methods in enzymology.

[48]  T. Knöpfel,et al.  Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism. , 2008, Human molecular genetics.

[49]  J Kerby,et al.  Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis. , 2001, Analytical biochemistry.

[50]  G. Veeneman,et al.  Non-steroidal steroid receptor modulators. , 2006, IDrugs : the investigational drugs journal.

[51]  Sami Kilpinen,et al.  Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling , 2008, Cell.

[52]  R. Boltz,et al.  Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. , 1998, The Journal of biological chemistry.

[53]  M. Lotze,et al.  Imaging analysis of STAT1 and NF-kappaB translocation in dendritic cells at the single cell level. , 2005, Drug discovery today.

[54]  P. Zandstra,et al.  Soluble Flt‐1 Regulates Flk‐1 Activation to Control Hematopoietic and Endothelial Development in an Oxygen‐Responsive Manner , 2008, Stem cells.

[55]  William R Mundy,et al.  Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. , 2008, Neurotoxicology.

[56]  E. Gelmann,et al.  Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. , 2004, Molecular endocrinology.

[57]  Samantha G. Zeitlin,et al.  Double-strand DNA breaks recruit the centromeric histone CENP-A , 2009, Proceedings of the National Academy of Sciences.

[58]  D. Agard,et al.  Mob4 plays a role in spindle focusing in Drosophila S2 cells , 2008, Journal of Cell Science.

[59]  T. Wassmer,et al.  A loss-of-function screen reveals SNX5 and SNX6 as potential components of the mammalian retromer , 2006, Journal of Cell Science.

[60]  G. Hager,et al.  Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. , 1999, Methods.

[61]  Charles Y. Tao,et al.  A Support Vector Machine Classifier for Recognizing Mitotic Subphases Using High-Content Screening Data , 2007, Journal of biomolecular screening.

[62]  Peter V. Henstock,et al.  Cellular imaging predictions of clinical drug-induced liver injury. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[63]  R. Lewensohn,et al.  The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[64]  G. C. Rogers,et al.  A multicomponent assembly pathway contributes to the formation of acentrosomal microtubule arrays in interphase Drosophila cells. , 2008, Molecular biology of the cell.

[65]  J. Downward,et al.  The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1 , 2007, Nature Cell Biology.

[66]  M. Banks,et al.  Coactivators in assay design for nuclear hormone receptor drug discovery. , 2003, Assay and drug development technologies.

[67]  Rui Wang,et al.  Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction. , 2009, Cardiovascular research.

[68]  B. K. Lundholt,et al.  Protein translocation assays: key tools for accessing new biological information with high-throughput microscopy. , 2006, Methods in enzymology.

[69]  G. Hager,et al.  Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  N. Morita,et al.  Real‐time imaging of glucocorticoid receptor dynamics in living neurons and glial cells in comparison with non‐neural cells , 1999, The European journal of neuroscience.

[71]  Lisa Morrison,et al.  Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases. , 2009, Blood.

[72]  T. Nielsen,et al.  Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy , 2007, Breast Cancer Research.

[73]  M. Kawata,et al.  Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. , 2001, Molecular endocrinology.

[74]  S. Barry,et al.  AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. , 2005, Cancer research.

[75]  G. Hager,et al.  Development of assays for nuclear receptor modulators using fluorescently tagged proteins. , 2006, Methods in enzymology.

[76]  W. Pratt,et al.  Chaperoning of glucocorticoid receptors. , 2006, Handbook of experimental pharmacology.

[77]  Andreas Vogt,et al.  The Benzo[c]phenanthridine Alkaloid, Sanguinarine, Is a Selective, Cell-active Inhibitor of Mitogen-activated Protein Kinase Phosphatase-1* , 2005, Journal of Biological Chemistry.

[78]  J. Dennis,et al.  Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.

[79]  Vineet Gupta,et al.  A Simple, No-Wash Cell Adhesion–Based High-Throughput Assay for the Discovery of Small-Molecule Regulators of the Integrin CD11b/CD18 , 2007, Journal of biomolecular screening.

[80]  P. Ross-Macdonald,et al.  Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors , 2008, Molecular Cancer Therapeutics.

[81]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[82]  Ximing J. Yang,et al.  Tumor suppressor activity of glucocorticoid receptor in the prostate , 2007, Oncogene.

[83]  W. Liu,et al.  Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. , 2008, Cancer research.

[84]  Duane D. Miller,et al.  Dissociated non-steroidal glucocorticoids: tuning out untoward effects , 2007, Expert opinion on therapeutic patents.

[85]  Jing Xu,et al.  Utility of Large-Scale Transiently Transfected Cells for Cell-Based High-Throughput Screens to Identify Transient Receptor Potential Channel A1 (TRPA1) Antagonists , 2007, Journal of biomolecular screening.

[86]  I. Pot,et al.  ING2 as a Novel Mediator of Transforming Growth Factor-β-dependent Responses in Epithelial Cells* , 2008, Journal of Biological Chemistry.

[87]  Adam T. Szafran,et al.  High-resolution, high-throughput microscopy analyses of nuclear receptor and coregulator function. , 2006, Methods in enzymology.

[88]  F. Marincola,et al.  The Pathway to Biomarker Discovery: Carbonic Anhydrase IX and the Prediction of Immune Responsiveness , 2005, Clinical Cancer Research.

[89]  Nicholas M. Radio,et al.  Protein biomarkers associated with growth and synaptogenesis in a cell culture model of neuronal development. , 2008, Toxicology.

[90]  R. Ye,et al.  Stereospecific Induction of Nuclear Factor-κB Activation by Isochamaejasmin , 2005, Molecular Pharmacology.

[91]  Kenneth A Giuliano,et al.  Multiplexed high content screening assays create a systems cell biology approach to drug discovery. , 2005, Drug discovery today.

[92]  P. Wipf,et al.  Cellular Analysis of Disorazole C1 and Structure–Activity Relationship of Analogs of the Natural Product , 2006, Chemical biology & drug design.

[93]  M. Kawata.  Subcellular steroid/nuclear receptor dynamics. , 2001, Archives of histology and cytology.

[94]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[95]  A. Prat,et al.  Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation , 2009, The Journal of Biological Chemistry.

[96]  J. Wrana,et al.  Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor β1 with Higher Affinity Receptors and an Activated Alk1 Pathway* , 2005, Journal of Biological Chemistry.

[97]  John W Funder,et al.  The evolution of mineralocorticoid receptors. , 2006, Molecular endocrinology.

[98]  Timothy J Shafer,et al.  Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[99]  Gillian R Richards,et al.  Quantitative assays of chemotaxis and chemokinesis for human neural cells. , 2004, Assay and drug development technologies.

[100]  R. K. Tyagi,et al.  Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. , 2000, Molecular endocrinology.

[101]  G. Chrousos,et al.  The Smad6-Histone Deacetylase 3 Complex Silences the Transcriptional Activity of the Glucocorticoid Receptor , 2005, Journal of Biological Chemistry.

[102]  Fang Zhang,et al.  Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening , 2009, Molecular Pharmacology.

[103]  D L Taylor,et al.  Real-time molecular and cellular analysis: the new frontier of drug discovery. , 2001, Current opinion in biotechnology.

[104]  Carol S. Lim,et al.  Geldanamycin, an inhibitor of Hsp90, Blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains , 2006, The AAPS Journal.

[105]  M. Pangalos,et al.  Ganglioside Inhibition of Neurite Outgrowth Requires Nogo Receptor Function , 2008, Journal of Biological Chemistry.

[106]  K. Vattem,et al.  Analysis of Signaling Pathways using Antibody Microarrays and RNA Interference , 2008 .

[107]  Kerby Shedden,et al.  Machine vision‐assisted analysis of structure‐localization relationships in a combinatorial library of prospective bioimaging probes , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[108]  Steven Gallinger,et al.  α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β In vivo, Inhibits Intestinal Tumor Progression , 2004, Cancer Research.

[109]  C. Porta,et al.  Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma , 2007, Clinical Cancer Research.

[110]  J. Lazo,et al.  Spatial Analysis of Key Signaling Proteins by High-content Solid-phase Cytometry in Hep3B Cells Treated with an Inhibitor of Cdc25 Dual-specificity Phosphatases* , 2001, The Journal of Biological Chemistry.

[111]  M. Morimoto,et al.  Imaging analysis of mineralocorticoid receptor and importins in single living cells by using GFP color variants , 2005, Cell and Tissue Research.

[112]  G. Chrousos,et al.  G protein β interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus , 2005, The Journal of cell biology.

[113]  D. F. Smith,et al.  Molecular chaperone interactions with steroid receptors: an update. , 2000, Molecular endocrinology.

[114]  S. Hirohashi,et al.  Dysadherin Expression Facilitates Cell Motility and Metastatic Potential of Human Pancreatic Cancer Cells , 2004, Cancer Research.

[115]  Y. Volkov,et al.  The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration. , 2006, Gastroenterology.

[116]  K Moore,et al.  Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel? , 2001, Journal of biomolecular screening.

[117]  Chad A. Cowan,et al.  Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate , 2009, The Journal of cell biology.

[118]  J. F. Schindler,et al.  Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation , 2009, Journal of Pharmacology and Experimental Therapeutics.

[119]  S. Grinstein,et al.  High-throughput assays of phagocytosis, phagosome maturation, and bacterial invasion. , 2007, American journal of physiology. Cell physiology.

[120]  Adam T. Szafran,et al.  Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility , 2006, Journal of cellular biochemistry.

[121]  L. Pearl,et al.  Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. , 1999, Journal of medicinal chemistry.

[122]  J. Lazo,et al.  A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity. , 2004, Oncology research.

[123]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[124]  J. Dennis,et al.  A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization , 2008, Apoptosis.

[125]  Yoshifumi Watanabe,et al.  Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor , 2006, Brain Research.

[126]  K. Yeow,et al.  Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.

[127]  A. Vandewalle,et al.  The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor , 2007, Molecular Pharmacology.

[128]  Sophie Malcomber,et al.  An assessment of the performance of an automated scoring system (Cellomics) for the in vitro micronucleus assay in CHO-K1 cells , 2007 .

[129]  J. Buckingham.  Glucocorticoids: exemplars of multi‐tasking , 2006, British journal of pharmacology.

[130]  J. Grandis,et al.  Human rhomboid family‐1 gene RHBDF1 participates in GPCR‐mediated transactivation of EGFR growth signals in head and neck squamous cancer cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[131]  G. C. Rogers,et al.  The SCFSlimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication , 2009, The Journal of cell biology.

[132]  R. Ye,et al.  The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding1 , 2006, The Journal of Immunology.

[133]  J. Davie,et al.  Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. , 1999, Molecular biology of the cell.

[134]  D. Zack,et al.  Oncomodulin links inflammation to optic nerve regeneration , 2009, Proceedings of the National Academy of Sciences.

[135]  S. Lamberts,et al.  Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome. , 2000, European journal of endocrinology.

[136]  R. Stearns,et al.  Acoustic auditing as a real-time, non-invasive quality control process for both source and assay plates. , 2005, Assay and drug development technologies.

[137]  M. Okabe,et al.  E-Cadherin-Coated Plates Maintain Pluripotent ES Cells without Colony Formation , 2006, PloS one.

[138]  J Fraser Glickman,et al.  A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors , 2002, Journal of biomolecular screening.

[139]  G. Vinson,et al.  Evidence for NL1-independent nuclear translocation of the mineralocorticoid receptor. , 2007, Biochemistry.